Odyssey Therapeutics, Inc. cotiza a 18.26 USD y tiene una capitalización bursátil de $878M. Datos fundamentales de la SEC EDGAR con hasta 20 años de histórico, insiders, institucionales y valoración DCF.Más empresas del sector Salud
Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002…
| Periodo | 2026-11 | 2026-08 | 2026-06 |
|---|---|---|---|
| Real | — | $-1.27 | $-6.75 |
| Estimado | $-0.96 | $-0.85 | $-1.28 |
| Sorpresa | — | -49.4% | -427.3% |
| Métrica | ODTX | Mediana Sector | Δ |
|---|---|---|---|
| Gross Margin | — | 57.0% | — |
| Operating Margin | — | -38.6% | — |
| Net Margin | — | -33.6% | — |
| FCF Margin | — | -13.9% | — |
| ROE | — | -40.4% | — |
| ROA | — | -32.0% | — |
| Current Ratio | 7.20 | 2.84 | +4.36 |
| Debt / Equity | — | 0.28 | — |